New Zealand markets close in 2 hours 26 minutes

Boston Scientific Corporation (BSX)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
38.02+1.08 (+2.92%)
At close: 04:00PM EDT
38.00 -0.02 (-0.05%)
After hours: 07:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 51.89B
Enterprise value 61.25B
Trailing P/E 68.49
Forward P/E 20.62
PEG ratio (5-yr expected) 2.16
Price/sales (ttm)4.29
Price/book (mrq)3.10
Enterprise value/revenue 5.04
Enterprise value/EBITDA 24.08

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 3-12.25%
S&P500 52-week change 3-8.83%
52-week high 347.50
52-week low 334.98
50-day moving average 340.35
200-day moving average 342.30

Share statistics

Avg vol (3-month) 38.88M
Avg vol (10-day) 311.59M
Shares outstanding 51.43B
Implied shares outstanding 6N/A
Float 81.42B
% held by insiders 10.24%
% held by institutions 193.11%
Shares short (30 May 2022) 415.18M
Short ratio (30 May 2022) 41.73
Short % of float (30 May 2022) 41.07%
Short % of shares outstanding (30 May 2022) 41.06%
Shares short (prior month 28 Apr 2022) 412.35M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 305 Nov 2003

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 6.66%
Operating margin (ttm)17.47%

Management effectiveness

Return on assets (ttm)4.20%
Return on equity (ttm)4.99%

Income statement

Revenue (ttm)12.16B
Revenue per share (ttm)8.54
Quarterly revenue growth (yoy)10.00%
Gross profit (ttm)8.24B
Net income avi to common (ttm)756M
Diluted EPS (ttm)0.53
Quarterly earnings growth (yoy)-67.70%

Balance sheet

Total cash (mrq)325M
Total cash per share (mrq)0.23
Total debt (mrq)9.68B
Total debt/equity (mrq)57.86
Current ratio (mrq)1.18
Book value per share (mrq)11.71

Cash flow statement

Operating cash flow (ttm)1.53B
Levered free cash flow (ttm)1.77B